{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:00:30Z","timestamp":1773414030984,"version":"3.50.1"},"publisher-location":"Cham","reference-count":151,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319729374","type":"print"},{"value":"9783319729381","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-72938-1_17","type":"book-chapter","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T07:38:57Z","timestamp":1521099537000},"page":"349-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Parkinson\u2019s Disease: Contemporary Concepts and Clinical Management"],"prefix":"10.1007","author":[{"given":"Vanessa","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Carlota Vicente","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Massano","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"17_CR1","volume-title":"An essay on the shaking palsy","author":"J Parkinson","year":"1817","unstructured":"Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, and Jones; 1817."},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"E Dorsey","year":"2007","unstructured":"Dorsey E, Constantinescu R, Thompson J, Biglan K, Holloway R, Kieburtz K. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384\u20136.","journal-title":"Neurology"},{"issue":"1","key":"17_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","volume":"18","author":"D Twelves","year":"2003","unstructured":"Twelves D, Perkins KSM, Uk M, Counsell C. Systematic review of incidence studies of Parkinson\u2019s disease. Mov Disord. 2003;18(1):19\u201331.","journal-title":"Mov Disord"},{"issue":"12","key":"17_CR4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u201372.","journal-title":"Lancet Neurol"},{"issue":"13","key":"17_CR5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"issue":"12","key":"17_CR6","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/mds.21153","volume":"21","author":"NU Okubadejo","year":"2006","unstructured":"Okubadejo NU, Bower JH, Rocca WA, Maraganore DM. Parkinson\u2019s disease in Africa: a systematic review of epidemiologic and genetic studies. Mov Disord. 2006;21(12):2150\u20136.","journal-title":"Mov Disord"},{"issue":"8","key":"17_CR7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF, Oyen WJG, Leenders KL, Eshuis S, et al. Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78(8):819\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"17_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000448402","volume":"47","author":"E Pupillo","year":"2016","unstructured":"Pupillo E, Cricelli C, Mazzoleni F, Cricelli I, Pasqua A, Pecchioli S, et al. Epidemiology of Parkinson\u2019s disease: a population-based study in primary care in Italy. Neuroepidemiology. 2016;47(1):38\u201345.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"17_CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ene.12592","volume":"22","author":"P Blin","year":"2015","unstructured":"Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jov\u00e9 J, et al. Parkinson\u2019s disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol. 2015;22(3):464\u201371.","journal-title":"Eur J Neurol"},{"issue":"5","key":"17_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.parkreldis.2013.01.014","volume":"19","author":"R Caslake","year":"2013","unstructured":"Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson\u2019s disease and parkinsonism in North East Scotland: the PINE study. Parkinsonism Relat Disord. 2013;19(5):515\u201321.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"17_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","volume":"15","author":"S Campenhausen Von","year":"2005","unstructured":"Von Campenhausen S, Bornschein B, Wick R, B\u00f6tzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson\u2019s disease in Europe. Eur Neuropsychopharmacol. 2005;15(4):473\u201390.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"17_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.25150","volume":"28","author":"K Kieburtz","year":"2013","unstructured":"Kieburtz K, Wunderle KB. Parkinson\u2019s disease: evidence for environmental risk factors. Mov Disord. 2013;28(1):8\u201313.","journal-title":"Mov Disord"},{"issue":"3","key":"17_CR13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Takkouche B, Caama\u00f1o-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann Neurol. 2002;52(3):276\u201384.","journal-title":"Ann Neurol"},{"issue":"7","key":"17_CR14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz B. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007;64(7):990.","journal-title":"Arch Neurol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/01.wnl.0000256374.50227.4b","volume":"68","author":"EE Calle","year":"2007","unstructured":"Calle EE, Thun MJ, Ascherio A, Thacker EL, Reilly EJO, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology. 2007;68:764\u20139.","journal-title":"Neurology"},{"issue":"11","key":"17_CR16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3181d55f38","volume":"74","author":"H Chen","year":"2010","unstructured":"Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74(11):878\u201384.","journal-title":"Neurology"},{"issue":"3","key":"17_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2005.065417","volume":"77","author":"AH Evans","year":"2006","unstructured":"Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2006;77(3):317\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11920-000-0027-1","volume":"2","author":"M Menza","year":"2000","unstructured":"Menza M. The personality associated with Parkinson\u2019s disease. Curr Psychiatry Rep. 2000;2:421\u20136.","journal-title":"Curr Psychiatry Rep"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.0000000000000879","volume":"83","author":"B Ritz","year":"2014","unstructured":"Ritz B, Lee P, Lassen CF, Lee P, Lassen CF. Parkinson disease and smoking revisited ease of quitting is an early sign of the disease. Neurology. 2014;83:1396\u2013402.","journal-title":"Neurology"},{"issue":"8","key":"17_CR20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2016.0947","volume":"73","author":"R Savica","year":"2016","unstructured":"Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol. 2016;73(8):981\u20139.","journal-title":"JAMA Neurol"},{"issue":"6","key":"17_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/aje\/kwn388","volume":"169","author":"J O\u2019Reilly","year":"2009","unstructured":"O\u2019Reilly J, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson\u2019s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169(6):678\u201382.","journal-title":"Am J Epidemiol"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/01.wnl.0000223618.53129.56","volume":"67","author":"GD Mellick","year":"2006","unstructured":"Mellick GD, Gartner CE, Silburn PA, Battistutta D. Passive smoking and Parkinson disease. Neurology. 2006;67:179\u201381.","journal-title":"Neurology"},{"issue":"10","key":"17_CR23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","volume":"27","author":"N Palacios","year":"2012","unstructured":"Palacios N, Gao X, Mccullough ML, Schwarzschild MA. Caffeine and risk of Parkinson\u2019s disease in a large cohort of men and women. Mov Disord. 2012;27(10):1276\u201382.","journal-title":"Mov Disord"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","volume":"60","author":"A Ascherio","year":"2003","unstructured":"Ascherio A, Chen H, Schwarzschild MA, Zhang SM. Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease. Neurology. 2003;60:790\u20135.","journal-title":"Neurology"},{"issue":"20","key":"17_CR25","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"GW Ross","year":"2000","unstructured":"Ross GW, Abbott RD, Petrovitch H, Morens DM, Curb JD, Popper JS. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283(20):2674\u20139.","journal-title":"JAMA"},{"issue":"20","key":"17_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2010-091525","volume":"20","author":"J Costa","year":"2010","unstructured":"Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis. 2010;20(20):221\u2013S238.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"17_CR27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/mds.25050","volume":"27","author":"N Palacios","year":"2012","unstructured":"Palacios N, Gao X, Reilly EO, Schwarzschild M, Mccullough ML, Mayo T, et al. Alcohol and risk of Parkinson\u2019s disease in a large, prospective cohort of men and women. Mov Disord. 2012;27(8):980\u20137.","journal-title":"Mov Disord"},{"issue":"0","key":"17_CR28","first-page":"1","volume":"0","author":"D Zhang","year":"2014","unstructured":"Zhang D, Jiang H. Alcohol intake and risk of Parkinson\u2019s disease: a meta-analysis of observational studies. Mov Disord. 2014;0(0):1\u20134.","journal-title":"Mov Disord"},{"issue":"1","key":"17_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2377-10-111","volume":"10","author":"W Fukushima","year":"2010","unstructured":"Fukushima W, Miyake Y, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, et al. Alcohol drinking and risk of Parkinson\u2019s disease: a case-control study in Japan. BMC Neurol. 2010;10(1):111.","journal-title":"BMC Neurol"},{"issue":"5","key":"17_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf MG, Reilly EO, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson\u2019s disease. Am J Epidemiol. 2007;166(5):561\u20137.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"17_CR31","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.24193","volume":"59","author":"MDE Vera","year":"2008","unstructured":"Vera MDE, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson\u2019s disease: a cohort study. Arthritis Rheum. 2008;59(11):1549\u201354.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"17_CR32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","volume":"65","author":"MA Schwarzschild","year":"2010","unstructured":"Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2010;65(6):716\u201323.","journal-title":"Arch Neurol"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000279518.10072.df","volume":"69","author":"A Alonso","year":"2010","unstructured":"Alonso A, Rodr\u00edguez LAG, Logroscino G, Hern\u00e1n MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2010;69:1696\u2013700.","journal-title":"Neurology"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clineuro.2009.06.012","volume":"111","author":"E Andreadou","year":"2009","unstructured":"Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, et al. Serum uric acid levels in patients with Parkinson\u2019s disease: their relationship to treatment and disease duration. Clin Neurol Neurosurg. 2009;111:724\u20138.","journal-title":"Clin Neurol Neurosurg"},{"key":"17_CR35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC. Anti-inflammatory drugs and risk of Parkinson disease. Neurology. 2010;74:995\u20132001.","journal-title":"Neurology"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E. Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol. 2005;58:963\u20137.","journal-title":"Ann Neurol"},{"key":"17_CR37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA. Use of ibuprofen and risk of Parkinson disease. Neurology. 2011;76:863\u20139.","journal-title":"Neurology"},{"issue":"6","key":"17_CR38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.24918","volume":"27","author":"RN Alcalay","year":"2012","unstructured":"Alcalay RN, Gu Y, Mejia-santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson\u2019s disease participants and methods. Mov Disord. 2012;27(6):771\u20134.","journal-title":"Mov Disord"},{"key":"17_CR39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","volume":"86","author":"X Gao","year":"2007","unstructured":"Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, FB H, et al. Prospective study of dietary pattern and risk of Parkinson disease 1\u00a0\u2013 3. Am J Clin Nutr. 2007;86:1486\u201394.","journal-title":"Am J Clin Nutr"},{"key":"17_CR40","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.0b013e31824f7fc4","volume":"78","author":"X Gao","year":"2013","unstructured":"Gao X, Cassidy A, Schwarzschild MA. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2013;78:1138\u201345.","journal-title":"Neurology"},{"key":"17_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/awu323","volume":"138","author":"F Yang","year":"2015","unstructured":"Yang F, Lagerros YT, Bellocco R, Adami H, Fang F, Pedersen NL, et al. Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort. Brain. 2015;138:269\u201375.","journal-title":"Brain"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.0b013e3181ea1597","volume":"75","author":"Q Xu","year":"2010","unstructured":"Xu Q, Park Y, Blair A. Physical activities and future risk of Parkinson disease. Neurology. 2010;75:341\u20138.","journal-title":"Neurology"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1353-8020(01)00054-2","volume":"8","author":"BCL Lai","year":"2002","unstructured":"Lai BCL, Marion SA, Teschke K, Tsui JKC. Occupational and environmental risk factors for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2002;8:297\u2013309.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"17_CR44","first-page":"1106","volume":"66","author":"CM Tanner","year":"2015","unstructured":"Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, et al. Occupation and risk of Parkinsonism. Arch Neurol. 2015;66(9):1106\u201313.","journal-title":"Arch Neurol"},{"key":"17_CR45","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/archneur.59.11.1787","volume":"59","author":"H Petrovitch","year":"2002","unstructured":"Petrovitch H, Ross GW, Abbott RD, Sanderson WT. Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol. 2002;59:1787\u201392.","journal-title":"Arch Neurol"},{"key":"17_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneur.62.1.91","volume":"62","author":"JA Firestone","year":"2015","unstructured":"Firestone JA, Smith-weller T, Franklin G, Swanson P, Longstreth WT, Checkoway H. Pesticides and risk of Parkinson disease. Arch Neurol. 2015;62:91\u20135.","journal-title":"Arch Neurol"},{"key":"17_CR47","first-page":"344","volume":"88","author":"BA Racette","year":"2016","unstructured":"Racette BA, Nielsen SS, Sheppard L, Seixas N, Warden MN. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neuroepidemiology. 2016;88:344\u201351.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"17_CR48","first-page":"30","volume":"250","author":"RD Abbott","year":"2003","unstructured":"Abbott RD, Ross GW, White LR, Sanderson WT, Burchfiel CM, Sharp DS, et al. Environmental, life-style, and physical precursors of clinical Parkinson\u2019s disease: recent findings from the Honolulu-Asia aging study. J Neurol. 2003;250(3):30\u20139.","journal-title":"J Neurol"},{"key":"17_CR49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/WNL.0000000000002254","volume":"86","author":"RD Abbott","year":"2015","unstructured":"Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, et al. Midlife milk consumption and substantia nigra neuron density at death. Neurology. 2015;86:512\u20139.","journal-title":"Neurology"},{"issue":"9","key":"17_CR50","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28(9):1222\u20139.","journal-title":"Mov Disord"},{"issue":"a2494","key":"17_CR51","first-page":"1","volume":"337","author":"K Rugbjerg","year":"2008","unstructured":"Rugbjerg K, Ritz B, Korbo L, Martinussen N. Risk of Parkinson\u2019s disease after hospital contact for head injury: population based case control study. BMJ. 2008;337(a2494):1\u201310.","journal-title":"BMJ"},{"issue":"13","key":"17_CR52","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/mds.25143","volume":"27","author":"F Fang","year":"2012","unstructured":"Fang F, Chen H, Ascertainment C. Head injury and Parkinson\u2019s disease: a population-based study. Mov Disord. 2012;27(13):1632\u20135.","journal-title":"Mov Disord"},{"issue":"6","key":"17_CR53","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ana.24396","volume":"77","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM. Traumatic brain injury in later life increases risk for Parkinson\u2019s disease. Ann Neurol. 2015;77(6):987\u201395.","journal-title":"Ann Neurol"},{"key":"17_CR54","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","volume":"76","author":"R Liu","year":"2011","unstructured":"Liu R, Lu Y. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76:2002\u20139.","journal-title":"Neurology"},{"issue":"5","key":"17_CR55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ede.0000229445.90471.5e","volume":"17","author":"JH Olsen","year":"2006","unstructured":"Olsen JH, Friis S, Frederiksen K. Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology. 2006;17(5):582\u20137.","journal-title":"Epidemiology"},{"issue":"1","key":"17_CR56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.21535","volume":"65","author":"X Gao","year":"2009","unstructured":"Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Genetic determinants of hair color and Parkinson\u2019s disease risk. Ann Neurol. 2009;65(1):76\u201382.","journal-title":"Ann Neurol"},{"issue":"12","key":"17_CR57","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/archneurol.2012.2261","volume":"69","author":"SA Kareus","year":"2012","unstructured":"Kareus SA, Figueroa KP, Cannon-Albright LA, Pulst SM. Shared predispositions of parkinsonism and cancer. Arch Neurol. 2012;69(12):1572\u20137.","journal-title":"Arch Neurol"},{"key":"17_CR58","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1212\/WNL.0b013e3181bd13a1","volume":"73","author":"X Gao","year":"2009","unstructured":"Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Family history of melanoma and Parkinson disease risk. Neurology. 2009;73:1286\u201391.","journal-title":"Neurology"},{"key":"17_CR59","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/jvh.12392","volume":"22","author":"W WY","year":"2015","unstructured":"WY W, Kang K, Chen SL, Chiu SY, Yen AM, Fann JC, et al. Hepatitis C virus infection: a risk factor for Parkinson\u2019s disease. J Viral Hepat. 2015;22:784\u201391.","journal-title":"J Viral Hepat"},{"key":"17_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003848","volume":"88","author":"J Pakpoor","year":"2017","unstructured":"Pakpoor J, Noyce A, Selkihova M, Lees A. Viral hepatitis and Parkinson disease. A national record-linkage study. Neurology. 2017;88:1\u20135.","journal-title":"Neurology"},{"key":"17_CR61","first-page":"1","volume":"86","author":"H Tsai","year":"2015","unstructured":"Tsai H, Liou H, Muo C, Lee C, Yen R, Kao C. Hepatitis C virus infection as a risk factor for Parkinson disease. Neurology. 2015;86:1\u20137.","journal-title":"Neurology"},{"key":"17_CR62","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. Mutation in the \u03b1-Synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137; (80) 2012","journal-title":"Science"},{"key":"17_CR63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00441-004-0924-4","volume":"27","author":"R Coelln","year":"2004","unstructured":"Coelln R, von Dawson VL, Dawson TM. Parkin-associated Parkinson\u2019s disease. Cell Tissue Res. 2004;27:175\u201384.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"17_CR64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A, Curie-paris PM, Umr S. Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009;18(1):48\u201359.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"17_CR65","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/brain\/aww080","volume":"139","author":"R Taipa","year":"2016","unstructured":"Taipa R, Melo-pires M, Magalha M, Alonso I. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain. 2016;139(6):1680\u20137.","journal-title":"Brain"},{"issue":"21","key":"17_CR66","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"B Christoph","year":"2000","unstructured":"Christoph B, L\u00fccking CB, D\u00fcrr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Den\u00e8fle P, Wood NW, Agid Y, Brice A, French Parkinson\u2019s Disease Genetics Study Group, European Consortium on Genetic Susceptibility in Parkinson\u2019s Disease. Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene. N Engl J Med. 2000;342(21):1560\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"17_CR67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archneur.65.6.802","volume":"65","author":"R Kumazawa","year":"2008","unstructured":"Kumazawa R, Tomiyama H, Li Y, Imamichi Y, Funayama M, Yoshino H, et al. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. Arch Neurol. 2008;65(6):802\u20138.","journal-title":"Arch Neurol"},{"key":"17_CR68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","volume":"79","author":"S Olgiati","year":"2016","unstructured":"Olgiati S, Quadri M, Fang M, Rood JPMA, Saute JA, Chien HF, et al. DNAJC6 mutations associated with early-onset Parkinson\u2019s disease. Ann Neurol. 2016;79:244\u201356.","journal-title":"Ann Neurol"},{"issue":"4","key":"17_CR69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.26527","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C, Lang A, van de Warrenburg BP, Sue CM. Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force. Mov Disord. 2016;31(4):436\u201357.","journal-title":"Mov Disord"},{"key":"17_CR70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.parkreldis.2007.11.013","volume":"14","author":"C Wider","year":"2008","unstructured":"Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism Relat Disord. 2008;14:465\u201370.","journal-title":"Parkinsonism Relat Disord"},{"key":"17_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXG.0000000000000009","volume":"1","author":"S Lesage","year":"2015","unstructured":"Lesage S, Bras J, Cormier- F, Condroyer C, Nicolas A, Darwent L, et al. Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease. Neurol Genet. 2015;1:1\u20133.","journal-title":"Neurol Genet"},{"key":"17_CR72","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","volume":"133","author":"L Samaranch","year":"2010","unstructured":"Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain. 2010;133:1128\u201343.","journal-title":"Brain"},{"key":"17_CR73","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","volume":"19","author":"\u00c7 K\u00f6roglu","year":"2013","unstructured":"K\u00f6roglu \u00c7, Baysal L, Cetinkaya M, Karasoy H, Tolun A. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat Disord. 2013;19:320\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"17_CR74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0036458","volume":"7","author":"S Edvardson","year":"2012","unstructured":"Edvardson S, Cinnamon Y, Ta-shma A, Shaag A, Yim Y, Zenvirt S, et al. A deleterious mutation in DNAJC6 encoding the Auxilin, is associated with juvenile parkinsonism. PLoS One. 2012;7(5):4\u20138.","journal-title":"PLoS One"},{"key":"17_CR75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","volume":"89","author":"C Vilari\u00f1o-Guell","year":"2011","unstructured":"Vilari\u00f1o-Guell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011;89:162\u20137.","journal-title":"Am J Hum Genet"},{"issue":"14","key":"17_CR76","first-page":"1","volume":"4422","author":"M Funayama","year":"2015","unstructured":"Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. Articles CHCHD 2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study. Lancet Glob Health. 2015;4422(14):1\u20139.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"17_CR77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","volume":"95","author":"GR Wilson","year":"2014","unstructured":"Wilson GR, Sim JCH, Mclean C, Giannandrea M, Galea CA, Riseley JR, et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with a -Synuclein pathology. Am J Hum Genet. 2014;95(6):729\u201335.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"17_CR78","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","volume":"124","author":"H Houlden","year":"2013","unstructured":"Houlden H, Singleton AB. The genetics and neuropathology of Parkinson\u2019s disease. Acta Neuropathol. 2013;124(3):325\u201338.","journal-title":"Acta Neuropathol"},{"key":"17_CR79","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","volume":"89","author":"M-C Chartier-Harlin","year":"2011","unstructured":"Chartier-Harlin M-C, Dachsel JC, Vilari\u00f1o-Guell C, Lincoln SJ, Lepretre F, Hulihan MM, et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet. 2011;89:398\u2013406.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"17_CR80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.12616","volume":"135","author":"M Ferreira","year":"2017","unstructured":"Ferreira M, Massano J. An updated review of Parkinson\u2019s disease genetics and clinicopathological correlations. Acta Neurol Scand. 2017;135(3):273\u201384.","journal-title":"Acta Neurol Scand"},{"key":"17_CR81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/WCO.0000000000000384","volume":"29","author":"R Coelln von","year":"2016","unstructured":"von Coelln R, Shulman LM. Clinical subtypes and genetic heterogeneity of lumping and splitting in Parkinson disease. Curr Opin Neurol. 2016;29:727\u201334.","journal-title":"Curr Opin Neurol"},{"key":"17_CR82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1353-8020(11)70004-9","volume":"18","author":"V Bonifati","year":"2012","unstructured":"Bonifati V. Autosomal recessive parkinsonism. Parkinsonism Relat Disord. 2012;18:4\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"17_CR83","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","volume":"19","author":"A Puschmann","year":"2013","unstructured":"Puschmann A. Parkinsonism and related disorders monogenic Parkinson\u2019s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord. 2013;19(4):407\u201315.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"17_CR84","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1212\/NXG.0000000000000098","volume":"2","author":"J Hirst","year":"2016","unstructured":"Hirst J, Madeo M, Edgar JR, Yarrow A, Deconinck T, Baets J, et al. Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48). Neurol Genet. 2016;2(5):e98.","journal-title":"Neurol Genet"},{"issue":"3","key":"17_CR85","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrneurol.2016.14","volume":"12","author":"JF Baizabal-carvallo","year":"2016","unstructured":"Baizabal-carvallo JF, Jankovic J. Parkinsonism, movement disorders and genetics in frontotemporal dementia Jos\u00e9. Nat Rev Neurol. 2016;12(3):175\u201385.","journal-title":"Nat Rev Neurol"},{"key":"17_CR86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00415-013-7216-4","volume":"261","author":"M Mallaret","year":"2014","unstructured":"Mallaret M, Lagha-Boukbiza O, Biskup S, Jacques I, Gabrielle N, Anheim M, et al. SPG15: a cause of juvenile atypical levodopa responsive parkinsonism. J Neurol. 2014;261:435\u20137.","journal-title":"J Neurol"},{"key":"17_CR87","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.parkreldis.2015.05.012","volume":"21","author":"T Stephanie","year":"2015","unstructured":"Stephanie T. Hirschbichler. Classic PD-like rest tremor associated with the tau p.R406W mutation. Parkinsonism Relat Disord. 2015;21:1002\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"17_CR88","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009;361:1651\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"17_CR89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson\u2019s disease: progress and therapeutic implications monogenic loci. Mov Disord. 2013;28(1):14\u201323.","journal-title":"Mov Disord"},{"issue":"a008888","key":"17_CR90","first-page":"1","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A. Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(a008888):1\u201315.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2 Pt 1","key":"17_CR91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lpm.2017.01.001","volume":"46","author":"A Delamarre","year":"2017","unstructured":"Delamarre A, Meissner WG. Epidemiology, environmental risk factors and genetics of Parkinson\u2019s disease. Presse Med. 2017;46(2 Pt 1):175\u201381.","journal-title":"Presse Med"},{"issue":"9766","key":"17_CR92","first-page":"641","volume":"377","author":"International Parkinson Disease Genomics Consortium","year":"2013","unstructured":"International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet. 2013;377(9766):641\u20139.","journal-title":"Lancet"},{"issue":"12","key":"17_CR93","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150\u20137.","journal-title":"Lancet Neurol"},{"key":"17_CR94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredic K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396:67\u201372.","journal-title":"Neurosci Lett"},{"key":"17_CR95","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredic K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019 s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"17_CR96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W. The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol. 2008;115:409\u201315.","journal-title":"Acta Neuropathol"},{"key":"17_CR97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday GM, Mccann H. The progression of pathology in Parkinson s disease. Ann N Y Acad Sci. 2010;1184:188\u201395.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"17_CR98","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J Li","year":"2008","unstructured":"Li J, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019 s disease suggest host-to-graft disease propagation. Nat Med. 2008;14(5):501\u20133.","journal-title":"Nat Med"},{"issue":"5","key":"17_CR99","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body\u00a0\u2013 like pathology in long-term embryonic nigral transplants in Parkinson\u2019 s disease. Nat Med. 2008;14(5):504\u20136.","journal-title":"Nat Med"},{"issue":"2","key":"17_CR100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2011.11.003","volume":"97","author":"CJR Dunning","year":"2012","unstructured":"Dunning CJR, Reyes JF, Steiner JA, Brundin P. Progress in neurobiology can Parkinson\u2019s disease pathology be propagated from one neuron to another? Prog Neurobiol. 2012;97(2):205\u201319.","journal-title":"Prog Neurobiol"},{"key":"17_CR101","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/WCO.0000000000000349","volume":"29","author":"P Brundin","year":"2016","unstructured":"Brundin P, Ma J, Kordower JH. How strong is the evidence that Parkinson\u2019s disease is a prion disorder? Curr Opin Neurol. 2016;29:459\u201366.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"17_CR102","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2016","unstructured":"Goedert M, Masuda-suzukake M, Falcon B. Like prions: the propagation of aggregated tau and a-synuclein in neurodegeneration. Brain. 2016;140(2):266\u201378.","journal-title":"Brain"},{"issue":"4","key":"17_CR103","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-suzukake","year":"2013","unstructured":"Masuda-suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, et al. Prion-like spreading of pathological a-synuclein in brain. Brain. 2013;136(4):1128\u201338.","journal-title":"Brain"},{"issue":"32","key":"17_CR104","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee H, Bae E, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 2009;106(32):13010\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR105","first-page":"1","volume":"11","author":"L Klingelhoefer","year":"2014","unstructured":"Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease\u00a0\u2014 the gut\u00a0\u2013 brain axis and environmental factors. Nat Rev Neurol. 2014;11:1\u201312.","journal-title":"Nat Rev Neurol"},{"key":"17_CR106","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-dutoit SJ. Pathological a-Synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol. 2016;79:940\u20139.","journal-title":"Ann Neurol"},{"key":"17_CR107","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H. Review: Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"17_CR108","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, S\u00f8rensen HT. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78:522\u20139.","journal-title":"Ann Neurol"},{"issue":"6","key":"17_CR109","first-page":"1","volume":"2","author":"KP Bhatia","year":"2012","unstructured":"Bhatia KP, Massano J. Clinical approach to Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(6):1\u201316.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"17_CR110","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"17_CR111","first-page":"1047","volume":"22","author":"CW Hess","year":"2016","unstructured":"Hess CW, Okun MS. Diagnosing Parkinson disease. Neurol Contin. 2016;22(4):1047\u201363.","journal-title":"Neurol Contin"},{"issue":"7","key":"17_CR112","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435\u201350. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"17_CR113","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.22464","volume":"24","author":"M Witt","year":"2009","unstructured":"Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Reichmann H, et al. Biopsies of olfactory epithelium in patients with Parkinson\u2019s disease. Mov Disord. 2009;24(6):906\u201314.","journal-title":"Mov Disord"},{"key":"17_CR114","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain. 2002;125:391\u2013403.","journal-title":"Brain"},{"key":"17_CR115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3174\/ajnr.A2350","volume":"32","author":"J Wang","year":"2011","unstructured":"Wang J, You H, Liu J. Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. Am J Neuroradiol. 2011;32:677\u201381.","journal-title":"Am J Neuroradiol"},{"key":"17_CR116","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2415-12-54","volume":"12","author":"EE Tsironi","year":"2012","unstructured":"Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinson\u2019s disease. BMC Ophthalmol. 2012;12:54.","journal-title":"BMC Ophthalmol"},{"key":"17_CR117","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/brain\/awt005","volume":"136","author":"NK Archibald","year":"2013","unstructured":"Archibald NK, Hutton SB, Clarke MP, Mosimann UP, Burn DJ. Visual exploration in Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Brain. 2013;136:739\u201350.","journal-title":"Brain"},{"issue":"5","key":"17_CR118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G. Pains in Parkinson disease\u00a0\u2014 many syndromes. Nat Rev Neurol. 2012;8(5):284\u201394.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"17_CR119","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.26270","volume":"30","author":"KR Chaudhuri","year":"2015","unstructured":"Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S. King\u2019s Parkinson\u2019s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord. 2015;30(12):1623\u201331.","journal-title":"Mov Disord"},{"key":"17_CR120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","volume":"35","author":"C Mcdonald","year":"2016","unstructured":"Mcdonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson\u2019s disease: prevalence, aetiology and management. Parkinsonism Relat Disord. 2016;35:8\u201316.","journal-title":"Parkinsonism Relat Disord"},{"key":"17_CR121","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0000000000000801","volume":"83","author":"P Riva de","year":"2014","unstructured":"de Riva P, Smith K, Xie SX, Weintraub D. Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology. 2014;83:1096\u2013103.","journal-title":"Neurology"},{"key":"17_CR122","doi-asserted-by":"crossref","unstructured":"Postuma RB, Berg D. The new diagnostic criteria for Parkinson\u2019s disease. In: Parkinson\u2019s disease, vol. 132. 1st ed: Elsevier; 2017. p. 55\u201378.","DOI":"10.1016\/bs.irn.2017.01.008"},{"key":"17_CR123","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","volume":"115","author":"R Sakakibara","year":"2008","unstructured":"Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T. Review article. Bladder and bowel dysfunction in Parkinson\u2019s disease. J Neural Transm. 2008;115:443\u201360.","journal-title":"J Neural Transm"},{"key":"17_CR124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","volume":"16","author":"DS Goldstein","year":"2006","unstructured":"Goldstein DS. Orthostatic hypotension as an early finding in Parkinson\u2019s disease. Clin Auton Res. 2006;16:46\u201354.","journal-title":"Clin Auton Res"},{"issue":"11","key":"17_CR125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016;12(11):622\u201334.","journal-title":"Nat Rev Neurol"},{"key":"17_CR126","first-page":"217","volume":"2","author":"M Pilleri","year":"2013","unstructured":"Pilleri M, Levedianos G, Weis L, Gasparoli E, Facchini S, Biundo R, et al. Parkinsonism and related disorders heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. Parkinsonism Relat Disord. 2013;2:217\u201321.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"17_CR127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord. 2008;23(2):183\u20139.","journal-title":"Mov Disord"},{"issue":"2","key":"17_CR128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"H Dominic","year":"2017","unstructured":"Dominic H, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, et al. The psychosis spectrum in Parkinson disease. Nat Rev Neurol. 2017;13(2):81\u201395.","journal-title":"Nat Rev Neurol"},{"key":"17_CR129","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","volume":"83","author":"JBM Anang","year":"2014","unstructured":"Anang JBM, Bertrand J, Romenets SR, Latreille V, Panisset M, Montplaisir J, et al. Predictors of dementia in Parkinson disease. A prospective cohort study. Neurology. 2014;83:1253\u201360.","journal-title":"Neurology"},{"key":"17_CR130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"17_CR131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/WNL.0000000000002876","volume":"87","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Copetti M, Arcuti S, Martino D. Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis. Neurology. 2016;87(2):237\u20138.","journal-title":"Neurology"},{"issue":"11","key":"17_CR132","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/mds.26721","volume":"31","author":"BF Boeve","year":"2016","unstructured":"Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, et al. Arguing against the proposed definition changes of PD. Mov Disord. 2016;31(11):1619\u201322.","journal-title":"Mov Disord"},{"issue":"12","key":"17_CR133","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u20139.","journal-title":"Mov Disord"},{"issue":"4 Movement Diso","key":"17_CR134","first-page":"1104","volume":"22","author":"JM Miyasaki","year":"2016","unstructured":"Miyasaki JM. Treatment of advanced Parkinson disease and related disorders. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1104\u201316.","journal-title":"Continuum (Minneap Minn)"},{"issue":"8","key":"17_CR135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrneurol.2012.126","volume":"8","author":"M Coelho","year":"2012","unstructured":"Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012;8(8):435\u201342.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"17_CR136","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","volume":"20","author":"JJ Ferreira","year":"2013","unstructured":"Ferreira JJ, Katzenschlager R, Bloem BR, et al. Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson\u2019s disease. Eur J Neurol. 2013;20(1):5\u201315.","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"17_CR137","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.23829","volume":"26","author":"SH Fox","year":"2011","unstructured":"Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord. 2011;26(Suppl 3):S2\u201341.","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"17_CR138","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","volume":"26","author":"K Seppi","year":"2011","unstructured":"Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease. Mov Disord. 2011;26(Suppl 3):S42\u201380.","journal-title":"Mov Disord"},{"issue":"11","key":"17_CR139","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181d55f24","volume":"74","author":"TA Zesiewicz","year":"2010","unstructured":"Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(11):924\u201331.","journal-title":"Neurology"},{"issue":"2","key":"17_CR140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","volume":"13","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Brundin P, Lang AE. Precision medicine for disease modification in Parkinson disease. Nat Rev Neurol. 2017;13(2):119\u201326.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"17_CR141","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamaneurol.2017.0348","volume":"74","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Lang AE. Common myths in the use of levodopa in Parkinson disease: when clinical trials misinform clinical practice. JAMA Neurol. 2017;74(6):633\u20134.","journal-title":"JAMA Neurol"},{"issue":"2","key":"17_CR142","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ene.12751","volume":"23","author":"NW Scott","year":"2016","unstructured":"Scott NW, Macleod AD, Counsell CE. Motor complications in an incident Parkinson\u2019s disease cohort. Eur J Neurol. 2016;23(2):304\u201312.","journal-title":"Eur J Neurol"},{"issue":"11","key":"17_CR143","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mds.26362","volume":"30","author":"O Rascol","year":"2015","unstructured":"Rascol O, Perez-Lloret S, Ferreira JJ. New treatments for levodopa-induced motor complications. Mov Disord. 2015;30(11):1451\u201360.","journal-title":"Mov Disord"},{"key":"17_CR144","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00415-014-7254-6","volume":"261","author":"L Perestelo-P\u00e9rez","year":"2014","unstructured":"Perestelo-P\u00e9rez L, Rivero-Santana A, P\u00e9rez-Ramos J, et al. Deep brain stimulation in Parkinson\u2019s disease: meta-analysis of randomized controlled trials. J Neurol. 2014;261:2051\u201360.","journal-title":"J Neurol"},{"issue":"7","key":"17_CR145","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WMM Schuepbach","year":"2013","unstructured":"Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med. 2013;368(7):610\u201322.","journal-title":"N Engl J Med"},{"key":"17_CR146","doi-asserted-by":"publisher","unstructured":"Mansouri A, Taslimi S, Badhiwala JH. et al, Deep brain stimulation for Parkinson\u2019s disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2017. https:\/\/doi.org\/10.3171\/2016.11.JNS16715 .","DOI":"10.3171\/2016.11.JNS16715"},{"issue":"11","key":"17_CR147","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00415-012-6798-6","volume":"260","author":"J Volkmann","year":"2013","unstructured":"Volkmann J, Albanese A, Antonini A, et al. Selecting deep brain stimulation or infusion therapies in advanced Parkinson\u2019s disease: an evidence-based review. J Neurol. 2013;260(11):2701\u201314.","journal-title":"J Neurol"},{"issue":"10","key":"17_CR148","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parkreldis.2009.09.005","volume":"15","author":"CE Clarke","year":"2009","unstructured":"Clarke CE, Worth P, Grosset D, Stewart D. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson\u2019s disease. Parkinsonism Relat Disord. 2009;15(10):728\u201341.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"17_CR149","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.parkreldis.2015.09.005","volume":"22","author":"G Abbruzzese","year":"2016","unstructured":"Abbruzzese G, Marchese R, Avanzino L, Pelosin E. Rehabilitation for Parkinson's disease: current outlook and future challenges. Parkinsonism Relat Disord. 2016;22(Suppl 1):S60\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"17_CR150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/revneuro-2012-0087","volume":"24","author":"R Grazina","year":"2013","unstructured":"Grazina R, Massano J. Physical exercise and Parkinson\u2019s disease: influence on symptoms, disease course and prevention. Rev Neurosci. 2013;24(2):139\u201352.","journal-title":"Rev Neurosci"},{"key":"17_CR151","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21035\/ijcnmh.2014.1.7","volume":"1","author":"A Monteiro","year":"2014","unstructured":"Monteiro A, Massano J. Parkinson\u2019s disease cluster: the wind of change. Int J Clin Neurosci Mental Health. 2014;1:7. https:\/\/doi.org\/10.21035\/ijcnmh.2014.1.7 .","journal-title":"Int J Clin Neurosci Mental Health"}],"container-title":["Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-72938-1_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T18:55:42Z","timestamp":1570906542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-72938-1_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319729374","9783319729381"],"references-count":151,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-72938-1_17","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}